Association of Genetic Polymorphisms in the VKORC1 and CYP2C9 Genes with Warfarin Dosage in a Group of Kuwaiti Individuals

被引:0
|
作者
Maryam H. Alrashid
Ahmad Al-Serri
Salem H. Alshemmari
Philip Koshi
Suzanne A. Al-Bustan
机构
[1] Kuwait University,Department of Biological Sciences, Faculty of Science
[2] Kuwait University,Department of Pathology, Faculty of Medicine
[3] Kuwait University,Department of Medicine, Faculty of Medicine
来源
关键词
Warfarin; International Normalization Ratio; Single Nucleotide Polymorphism; Warfarin Dose; Warfarin Dose Requirement;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:183 / 190
页数:7
相关论文
共 50 条
  • [31] VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients
    Ozgon, G. Oner
    Langaee, T. Y.
    Feng, H.
    Buyru, N.
    Ulutin, T.
    Hatemi, A. C.
    Siva, A.
    Saip, S.
    Johnson, J. A.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (09) : 889 - 894
  • [32] Correction to: The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians
    Ahmed M. L. Bedewy
    Salah A. Sheweita
    Mostafa Hasan Mostafa
    Lamia Saeed Kandil
    Indian Journal of Hematology and Blood Transfusion, 2018, 34 : 337 - 337
  • [33] Non-genetic factors and polymorphisms in genes CYP2C9 and VKORC1: predictive algorithms for TTR in Brazilian patients on warfarin
    Praxedes, Marcus Fernando S.
    Martins, Maria Auxiliadora P.
    Mourao, Aline O. M.
    Gomes, Karina B.
    Reis, Edna A.
    Souza, Renan P.
    Campos, Emilio Itamar F.
    Ribeiro, Daniel D.
    Rocha, Manoel Otavio C.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (02) : 199 - 209
  • [34] Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin
    Flockhart, David A.
    O'Kane, Dennis
    Williams, Marc S.
    Watson, Michael S.
    Flockhart, David A.
    Gage, Brian
    Gandolfi, Roy
    King, Richard
    Lyon, Elaine
    Nussbaum, Robert
    O'Kane, Dennis
    Schulman, Kevin
    Veenstra, David
    Williams, Marc S.
    Watson, Michael S.
    GENETICS IN MEDICINE, 2008, 10 (02) : 139 - 150
  • [35] Frequency of CYP2C9 and VKORC1 Polymorphisms Affecting Warfarin Metabolism in an Indian Population
    Das, B.
    Chheda, P.
    Khadapkar, R. D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 625 - 625
  • [36] Polymorphism of the CYP2C9 and VKORC1 genes: a comment
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    JORNAL VASCULAR BRASILEIRO, 2021, 20
  • [37] Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population
    Giri, Anil K.
    Khan, Nazir M.
    Grover, Sandeep
    Kaur, Ismeet
    Basu, Analabha
    Tandon, Nikhil
    Scaria, Vinod
    Kukreti, Ritushree
    Brahmachari, Samir K.
    Bharadwaj, Dwaipayan
    PHARMACOGENOMICS, 2014, 15 (10) : 1337 - 1354
  • [38] Non-genetic factors and polymorphisms in genes CYP2C9 and VKORC1: predictive algorithms for TTR in Brazilian patients on warfarin
    Marcus Fernando S. Praxedes
    Maria Auxiliadora P. Martins
    Aline O. M. Mourão
    Karina B. Gomes
    Edna A. Reis
    Renan P. Souza
    Emílio Itamar F. Campos
    Daniel D. Ribeiro
    Manoel Otávio C. Rocha
    European Journal of Clinical Pharmacology, 2020, 76 : 199 - 209
  • [39] VKORC1 and CYP2C9 genetic polymorphisms in hepatic or portal vein thrombosis
    Pasmant, Eric
    de Beauvoir, Charlotte
    Plessier, Aurelie
    Labreuche, Julien
    Bezeaud, Annie
    THROMBOSIS RESEARCH, 2010, 126 (02) : E134 - E136
  • [40] Effect of VKORC1 and CYP2C9 variants on dosage of oral anticoagulants in Chilean individuals
    Benavides, Felipe
    Grossman, Nicole
    Poggi, Helena
    Nieto, Elena
    Bertran, Antonio
    Araos, Daniel
    Vasquez, Marcos
    Ibarra, Ignaz
    Caceres, Felipe
    Espinoza, Karena
    Lagos, Marcel
    Repetto M, Gabriela
    REVISTA MEDICA DE CHILE, 2015, 143 (11) : 1369 - 1376